Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
- PMID: 35937020
- PMCID: PMC9347693
- DOI: 10.1002/ccr3.6122
Early onset of scleromyxedema Arndt-Gottron associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins
Abstract
Arndt-Gottron (S-AG) syndrome or scleromyxedema is a scarce disease characterized by a generalized papular and sclerodermoid eruption and systemic manifestations that can lead to significant morbid-mortality. Interesting, S-AG can be associated with a paraprotein. We report an exceptional scleromyxedema case associated with a benign monoclonal gammapathy in an old woman.
Keywords: Arndt‐Gottron syndrome; monoclonal gammapathy; scleromyxedema; treatment.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
References
-
- Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol. 2006;24(6):493‐497. - PubMed
-
- Rongioletti F. Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg. 2006;25(2):100‐104. - PubMed
-
- Heymann WR. Scleromyxedema. J Am Acad Dermatol. 2007;57(5):890‐891. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
